Motor skills study for children with FSHD
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study looks at how children with FSHD move and function over time. It uses walking tests and optional MRI scans to understand muscle changes. Your child's participation could help researchers learn more about FSHD progression in kids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 17 years old.
- They must have a genetic diagnosis of FSHD (type 1 or 2).
- They should have muscle weakness in the face, shoulders, belly, or legs.
- They must be able to walk 10 meters (about the length of a school bus) in under 12 seconds, with or without a cane or brace.
- Up to 8 kids who walk slower than 12 seconds or use a wheelchair may also join.
- Your child must be willing to try an MRI scan at least once.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an investigational drug, SRP-1001, to see if it helps people with facioscapulohumeral muscular dystrophy type 1 (FSHD1), a condition that causes muscle weakness. The study will check if the drug is safe and if it can slow down the loss of muscle function.
This study looks at how children and teens with Duchenne muscular dystrophy (DMD) or spinal muscular atrophy (SMA) walk, by having them do walking tests while wearing sensors. The goal is to find better ways to track how these diseases progress and how treatments work over time, without needing blood tests or scans.
This trial tests a new stem cell treatment (ULSC) for people with FSHD, a type of muscular dystrophy. It aims to see if the treatment is safe and if it can help improve arm strength and daily movement.
This study looks at muscle MRI images and walking patterns (3D gait analysis) in people with FSHD. It helps researchers understand how the disease affects movement and muscle over time.
This trial studies how well certain physical/movement tests work in people with facioscapulohumeral muscular dystrophy (FSHD). It may help clinicians measure changes more accurately and tailor care over time.
This study looks at how walking changes over time in people with facioscapulohumeral muscular dystrophy (FSHD). It aims to understand walking patterns to help improve future care.
Hear when a new Muscular Dystrophy, Facioscapulohumeral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.